- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-trimer
- Ligands
- 15 x NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 30 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.16: 4 residues within 4Å:- Chain A: N.123, A.124, T.125, N.126
Ligand excluded by PLIPNAG.17: 3 residues within 4Å:- Chain A: F.341, N.342, F.370
Ligand excluded by PLIPNAG.18: 3 residues within 4Å:- Chain A: Y.31, F.62, N.64
Ligand excluded by PLIPNAG.19: 2 residues within 4Å:- Chain A: N.164, N.165
Ligand excluded by PLIPNAG.20: 3 residues within 4Å:- Chain A: N.233, T.235
- Chain B: K.461
Ligand excluded by PLIPNAG.21: 2 residues within 4Å:- Chain A: N.330, Q.578
Ligand excluded by PLIPNAG.22: 3 residues within 4Å:- Chain A: N.614, T.616, Q.642
Ligand excluded by PLIPNAG.23: 1 residues within 4Å:- Chain A: N.655
Ligand excluded by PLIPNAG.24: 3 residues within 4Å:- Chain A: S.706, N.707
- Chain C: Y.794
Ligand excluded by PLIPNAG.25: 4 residues within 4Å:- Chain A: A.704, E.1070, N.1072
- Chain C: Q.893
Ligand excluded by PLIPNAG.26: 4 residues within 4Å:- Chain B: N.123, T.125, N.126, V.171
Ligand excluded by PLIPNAG.27: 3 residues within 4Å:- Chain B: F.341, N.342, F.370
Ligand excluded by PLIPNAG.28: 3 residues within 4Å:- Chain B: Y.31, F.62, N.64
Ligand excluded by PLIPNAG.29: 2 residues within 4Å:- Chain B: N.164, N.165
Ligand excluded by PLIPNAG.30: 3 residues within 4Å:- Chain B: N.233, T.235
- Chain C: K.461
Ligand excluded by PLIPNAG.31: 3 residues within 4Å:- Chain B: N.330, Q.578, L.580
Ligand excluded by PLIPNAG.32: 3 residues within 4Å:- Chain B: N.614, T.616, Q.642
Ligand excluded by PLIPNAG.33: 1 residues within 4Å:- Chain B: N.655
Ligand excluded by PLIPNAG.34: 3 residues within 4Å:- Chain A: Y.794
- Chain B: S.706, N.707
Ligand excluded by PLIPNAG.35: 4 residues within 4Å:- Chain A: Q.893
- Chain B: A.704, E.1070, N.1072
Ligand excluded by PLIPNAG.36: 5 residues within 4Å:- Chain C: N.123, A.124, T.125, N.126, V.171
Ligand excluded by PLIPNAG.37: 3 residues within 4Å:- Chain C: F.341, N.342, F.370
Ligand excluded by PLIPNAG.38: 3 residues within 4Å:- Chain C: Y.31, F.62, N.64
Ligand excluded by PLIPNAG.39: 2 residues within 4Å:- Chain C: N.164, N.165
Ligand excluded by PLIPNAG.40: 3 residues within 4Å:- Chain A: K.461
- Chain C: N.233, T.235
Ligand excluded by PLIPNAG.41: 2 residues within 4Å:- Chain C: N.330, Q.578
Ligand excluded by PLIPNAG.42: 3 residues within 4Å:- Chain C: N.614, T.616, Q.642
Ligand excluded by PLIPNAG.43: 1 residues within 4Å:- Chain C: N.655
Ligand excluded by PLIPNAG.44: 3 residues within 4Å:- Chain B: Y.794
- Chain C: S.706, N.707
Ligand excluded by PLIPNAG.45: 4 residues within 4Å:- Chain B: Q.893
- Chain C: A.704, E.1070, N.1072
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Liu, P. et al., Spike N354 glycosylation augments SARS-CoV-2 fitness for human adaptation through structural plasticity. Natl Sci Rev (2024)
- Release Date
- 2024-06-26
- Peptides
- Spike glycoprotein: ABC
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
C
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-trimer
- Ligands
- 15 x NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 30 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Liu, P. et al., Spike N354 glycosylation augments SARS-CoV-2 fitness for human adaptation through structural plasticity. Natl Sci Rev (2024)
- Release Date
- 2024-06-26
- Peptides
- Spike glycoprotein: ABC
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
C